Hemodynamic assessment of transitioning from parenteral prostacyclin to selexipag in pediatric pulmonary hypertension.

Colglazier E, Stevens L, Parker C, Nawaytou HM, Amin EK, Becerra J, Steurer M, Fineman JR

Open source

DOI
10.1002/pul2.12159
Published
2022 Oct
Container
Pulmonary circulation
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/pul2.12159,
  title = {Hemodynamic assessment of transitioning from parenteral prostacyclin to selexipag in pediatric pulmonary hypertension.},
  author = {Colglazier E and Stevens L and Parker C and Nawaytou HM and Amin EK and Becerra J and Steurer M and Fineman JR},
  year = {2022},
  journal = {Pulmonary circulation},
  doi = {10.1002/pul2.12159},
  url = {https://doi.org/10.1002/pul2.12159}
}

RIS

TY  - JOUR
TI  - Hemodynamic assessment of transitioning from parenteral prostacyclin to selexipag in pediatric pulmonary hypertension.
AU  - Colglazier E
AU  - Stevens L
AU  - Parker C
AU  - Nawaytou HM
AU  - Amin EK
AU  - Becerra J
AU  - Steurer M
AU  - Fineman JR
PY  - 2022
JO  - Pulmonary circulation
DO  - 10.1002/pul2.12159
UR  - https://doi.org/10.1002/pul2.12159
ER  - 

APA

E, C., L, S., C, P., HM, N., EK, A., J, B., M, S., & JR, F. (2022). Hemodynamic assessment of transitioning from parenteral prostacyclin to selexipag in pediatric pulmonary hypertension.. Pulmonary circulation. https://doi.org/10.1002/pul2.12159

Source records